Recent Updates in the Treatment of Chronic Lymphocytic Leukemia: Year in Review 2022 - Episode 1

Mechanism of Action of BTK Inhibitors in Chronic Lymphocytic Leukemia

, , ,

Susan O’Brien, MD, provides a brief overview of chronic lymphocytic leukemia (CLL), and Seema Ali Bhat, MD, explains the mechanism of BTK inhibitors.